TAF11 siRNA (Human)
SiRNA to inhibit TAF11 expression using RNA interference
Product Specifications
Product Name Alternative
TAF2I; Transcription initiation factor TFIID subunit 11; TFIID subunit p30-beta; Transcription initiation factor TFIID 28 kDa subunit; TAF (II) 28; TAFII-28; TAFII28
Reactivity
H
Source
Synthetic
Applications
RNAi
Purity
> 97%
Form
Lyophilized powder
Components
We offers pre-designed sets of 3 different target-specific siRNA oligo duplexes of human TAF11 gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot.
Storage Conditions
Shipped at 4 °C. Store at -20 °C for one year.
Specificity
TAF11 siRNA (Human) is a target-specific 19-23 nt siRNA oligo duplexes designed to knock down gene expression.
NCBI Gene Symbol
TAF11
Quality Control
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
SwissProt (Human)
Q15544
Entrez GeneHuman
6882
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GP-5901-5 1 mL
Colloidal Gold Conjugated Erythrina cristagalli Lectin (Coral Tree) -ECA-, 5nm
Sign In for Pricing
View Details 
BNC042268-500 1x 500 µL
Fas (TNFRSF6) associated factor 1 (CPTC-FAF1-2), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC683242-100 1x 100 µL
Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3242), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 